Memphis, TN, United States of America

Vincent J Kidd

This inventor holds 3 USPTO granted patents. Top assignee: St. Jude Children's Research Hospital. Active years: 2000-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincent J Kidd. Retrieved from https://idiyas.com/inventor/vincent-j-kidd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Cordova, TN (US) (2000 - 2001)
  • Memphis, TN (US) (2006)

Company Filing History:


Years Active: 2000-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Vincent J Kidd

Introduction

Vincent J Kidd is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of biomedical research, particularly in the area of tumor suppressor proteins and their implications in cancer diagnostics and therapeutics. With a total of 3 patents, his work has the potential to impact the understanding and treatment of various cancers.

Latest Patents

Vincent J Kidd's latest patents include groundbreaking inventions related to tumor suppressor proteins. One of his notable patents focuses on the tumor suppressor protein caspase-8 (CASP8), which is involved in death signaling. This invention relates to the identification of tumor suppressor activity of CASP8 and includes diagnostic and therapeutic compositions and methods. The discovery of CASP8's tumor suppressor activity provides valuable screening targets, particularly for compounds that can overcome gene inactivation due to genomic methylation of the promoter. His research indicates that CASP8 is functionally inactivated in over 90% of MYCN amplified neuroblastoma cell lines, with inactivation occurring through various mechanisms, including homozygous deletion and gene silencing by methylation.

Another significant patent by Kidd involves cyclin-C variants and their diagnostic and therapeutic uses. This invention includes alternatively and partially spliced cyclin C mRNAs, recombinant DNA, and the truncated protein they encode. The research demonstrates that at least one of the alternatively spliced cyclin C mRNAs is produced in a cell cycle-dependent manner, along with the novel truncated cyclin box protein it encodes. This truncated cyclin C acts as an inhibitor by negatively regulating the cyclin C/cdk8 complex activity.

Career Highlights

Vincent J Kidd is affiliated with St. Jude Children's Research Hospital, where he conducts his research. His work is instrumental in advancing the understanding of cancer biology and developing potential therapeutic strategies.

Collaborations

Some of his notable coworkers include Jill M Lahti and Tal Teitz, who contribute to the collaborative research efforts at St. Jude Children's Research Hospital.

Conclusion

Vincent J Kidd's innovative work in the field of tumor suppressor proteins and cancer research highlights his significant contributions to biomedical science. His patents reflect a commitment to advancing diagnostic and therapeutic approaches in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…